The stock of DiaMedica Inc (CVE:DMA) is a huge mover today! The stock decreased 7.14% or $0.02 on September 13, hitting $0.26. About 92,500 shares traded hands or 70.12% up from the average. DiaMedica Inc (CVE:DMA) has risen 6.00% since August 14, 2016 and is uptrending. It has underperformed by 10.49% the S&P500.
The move comes after 8 months negative chart setup for the $21.92 million company. It was reported on Sep, 13 by Barchart.com. We have $0.23 PT which if reached, will make CVE:DMA worth $2.63 million less.
DiaMedica Inc. is a clinical-stage biopharmaceutical company, which focuses on recombinant proteins and monoclonal antibodies. The company has a market cap of $21.92 million. The Firm focuses on the discovery and development of treatments for stroke and other vascular diseases. It currently has negative earnings. It operates through segment, which is discovery and development of recombinant proteins and monoclonal antibody technology applications to treat large unmet diseases, including acute vascular disease of the brain, kidneys and heart.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.